Graham K. Cooper - 27 Jan 2022 Form 4 Insider Report for Applied Molecular Transport Inc.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 27 Jan 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 31 Jan 2022, 16:37:38 UTC
Prior SEC filing: 08 Jul 2021
Next SEC filing: 13 May 2022
Source filing: View source filing
Reporting owner signature: /s/ Brandon Hants Attorney-in-Fact for Graham Cooper

Key filing fact

Graham K. Cooper filed Form 4 for Applied Molecular Transport Inc. on 31 Jan 2022.

Key facts

This page summarizes Graham K. Cooper's Form 4 filing for Applied Molecular Transport Inc..
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 31 Jan 2022, 16:37.

Change

Previous filing in this sequence was filed on 08 Jul 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AMTI transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +300,000
Change %
Price: $0.000000
Shares after: 300,000
Date: 27 Jan 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 300,000
Exercise price: $8.01
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

1/48th of the shares subject to the option shall vest and become exercisable on the Exercisable Date set forth above and 1/48th of the shares subject to the option shall vest monthly thereafter, provided that Reporting Person remains a service provider to the Issuer on each such vest date.